Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, S.
Right arrow Articles by Cordon-Cardo, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, S.
Right arrow Articles by Cordon-Cardo, C.
[Cancer Research 65, 2186-2192, March 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

p73ß-Mediated Apoptosis Requires p57kip2 Induction and IEX-1 Inhibition

Susana Gonzalez1,2, Manuel M. Perez-Perez1, Eva Hernando1, Manuel Serrano2 and Carlos Cordon-Cardo1

1 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York and 2 Molecular Oncology Program, Spanish National Cancer Centre, Madrid, Spain

Requests for reprints: Carlos Cordon-Cardo, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY. Phone: 212-639-7746; Fax: 212-794-3186; E-mail: sgonzalez{at}cnio.es.

Similarly to p53, p73{alpha} and p73ß induce growth arrest and/or apoptosis in response to DNA damage or when exogenously expressed. However, how they trigger apoptosis remains unresolved. After stable transduction of either p73{alpha} or p73ß, a greater apoptotic response was observed for p73ß in both primary and tumor cells. Consistently, blocking ectopic and endogenous p73ß expression by specific shRNA significantly decreased apoptotic levels after DNA damage. We found that p73ß targets the apoptotic program at multiple levels: (i) facilitating caspase activation through p53-dependent signals and (ii) inducing p57KIP2, while down-regulating c-IPA1 and IEX1 through a p53-independent mechanism. p73ß-mediated apoptosis was considerably reduced after inhibition of p57KIP2 by small interfering RNA, IEX-1 overexpression, and in mouse embryo fibroblasts derived from p57–/– mice. Data from this study offer evidence for the apoptotic activity exclusive of p73ß. In the clinical context, these results might have potential therapeutic implications, because p73ß could induce alternative apoptotic responses in tumors harboring p53 mutations.

Key Words: p73{alpha} • p73ß • apoptosis • tumorigenesis • cell cycle




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
T. Sasada, K. Azuma, T. Hirai, H. Hashida, M. Kanai, T. Yanagawa, and A. Takabayashi
Prognostic Significance of the Immediate Early Response Gene X-1 (IEX-1) Expression in Pancreatic Cancer
Ann. Surg. Oncol., February 1, 2008; 15(2): 609 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Shen, J. Guo, C. Santos-Berrios, and M. X. Wu
Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1
J. Biol. Chem., June 2, 2006; 281(22): 15304 - 15311.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.